This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Jul;16(7):2572-3.

doi: 10.1200/JCO.1998.16.7.2572.

Long-term pamidronate in multiple myeloma

PMID: 9667282
DOI: 10.1200/JCO.1998.16.7.2572

Comment

Long-term pamidronate in multiple myeloma

J F Seymour. J Clin Oncol. 1998 Jul.

. 1998 Jul;16(7):2572-3.

doi: 10.1200/JCO.1998.16.7.2572.

Author

PMID: 9667282
DOI: 10.1200/JCO.1998.16.7.2572

No abstract available

PubMed Disclaimer

Comment on

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone JF, Reitsma DJ, Heffernan M, Seaman J, Knight RD. Berenson JR, et al. J Clin Oncol. 1998 Feb;16(2):593-602. doi: 10.1200/JCO.1998.16.2.593. J Clin Oncol. 1998. PMID: 9469347 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information